Xiaoxu Jiang
Finanzdirektor/CFO bei Shanghai NewMed Medical Co., Ltd.
Profil
Xiaoxu Jiang is currently the Chief Financial Officer & Joint Secretary at Shanghai NewMed Medical Co., Ltd.
Prior to this, he held the position of Managing Director-Consumer & Healthcare Sector at CCB International Capital Ltd.
from 2017 to 2021.
He also worked as Vice President & Principal at Piper Jaffray Asia Securities Ltd.
from 2010 to 2017 and as an Associate at Susquehanna International Group LLP (China) from 2008 to 2009.
Additionally, Mr. Jiang briefly served as the Chief Financial Officer at Fosun Kite Biotechnology Co., Ltd.
in 2021 and as the Managing Partner at Shanghai Yijie Information Consulting Co., Ltd.
in 2017.
He obtained a graduate degree from the University of Iowa in 1999 and completed his undergraduate and graduate degrees at West China University of Medical Sciences in 1995 and 1996 respectively.
Mr. Jiang also holds an MBA from Columbia Business School, which he earned in 2005.
Aktive Positionen von Xiaoxu Jiang
| Unternehmen | Position | Beginn |
|---|---|---|
Shanghai NewMed Medical Co., Ltd.
 Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Finanzdirektor/CFO | 01.05.2021 |
Ehemalige bekannte Positionen von Xiaoxu Jiang
| Unternehmen | Position | Ende |
|---|---|---|
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Finanzdirektor/CFO | 01.05.2021 |
CCB International Capital Ltd.
 CCB International Capital Ltd. Investment Banks/BrokersFinance CCB International Capital Ltd. provides financial advisory and brokerage services. The company is based in Hong Kong, Hong Kong. The Chinese company is ultimately controlled by the Government of China. | Corporate Officer/Principal | 01.01.2021 |
| Shanghai Yijie Information Consulting Co., Ltd. | Vorstandsvorsitzender | 01.11.2017 |
| Piper Jaffray Asia Securities Ltd. | Corporate Officer/Principal | 01.02.2017 |
| Susquehanna International Group LLP (China) | Corporate Officer/Principal | 01.10.2009 |
Ausbildung von Xiaoxu Jiang
| University of Iowa | Graduate Degree |
| West China University of Medical Sciences | Graduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
| Piper Jaffray Asia Securities Ltd. | Finance |
CCB International Capital Ltd.
CCB International Capital Ltd. Investment Banks/BrokersFinance CCB International Capital Ltd. provides financial advisory and brokerage services. The company is based in Hong Kong, Hong Kong. The Chinese company is ultimately controlled by the Government of China. | Finance |
| Susquehanna International Group LLP (China) | |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Yijie Information Consulting Co., Ltd. |
